GES polypharmacology fingerprints: A novel approach for drug repositioning

Journal of Chemical Information and Modeling

Volumn 54, Issue 3, 2014, Pages 720-734

  Pérez Nueno, Violeta I ^a   Karaboga, Arnaud S ^a   Souchet, Michel ^a   Ritchie, David W ^b  

^a Espace Transfert   (France)

^b INRIA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL PROPERTIES;

CLINICAL DRUGS; DRUG DESIGN; DRUG REPOSITIONING; DRUG TARGETS; GAUSSIANS; HIGH-PRECISION; REPURPOSING; SIMILARITY SCORES;

LIGANDS;

DRUG; LIGAND;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG DATABASE; DRUG DESIGN; DRUG REPOSITIONING; NORMAL DISTRIBUTION; POLYPHARMACOLOGY; PROCEDURES;

DATABASES, PHARMACEUTICAL; DRUG DESIGN; DRUG REPOSITIONING; LIGANDS; MODELS, MOLECULAR; NORMAL DISTRIBUTION; PHARMACEUTICAL PREPARATIONS; POLYPHARMACOLOGY;

EID: 84896925864     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci4006723     Document Type: Article

References (50)

1. Azzaoui, K.; Hamon, J.; Faller, B.; Whitebread, S.; Jacoby, E.; Bender, A.; Jenkins, J. L.; Urban, L. Modeling promiscuity based on in vitro safety pharmacology profiling data ChemMedChem 2007, 2, 874-880
2. Chong, C. R.; Sullivan, D. J. New uses for old drugs Nature 2007, 448, 645-646
3. Carrieri, A.; Pérez-Nueno, V. I.; Lentini, G.; Ritchie, D. W. Recent trends and future prospects in computational GPCR drug discovery: From virtual screening to polypharmacology Curr. Top. Med. Chem. 2013, 13, 1069-1097
4. Nettles, J. H.; Jenkins, J. L.; Bender, A.; Deng, Z.; Davies, J. W.; Glick, M. Bridging chemical and biological space: "Target fishing" using 2D and 3D molecular descriptors J. Med. Chem. 2006, 49, 6802-6810
5. Keiser, M. J.; Roth, B. L.; Armbruster, B. N.; Ernsberger, P.; Irwin, J. J.; Shoichet, B. K. Relating protein pharmacology by ligand chemistry Nat. Biotechnol. 2007, 25, 197-206
6. Gregori-Puigjane, E.; Mestres, J. SHED: Shannon entropy descriptors from topological feature distributions J. Chem. Inf. Model. 2006, 46, 1615-1622
7. Vidal, D.; Mestres, J. In Silico Receptorome Screening of Antipsychotic Drugs Mol. Inf. 2010, 29, 543-551
8. AbdulHameed, M. D. M.; Chaudhury, S.; Singh, N.; Sun, H.; Wallqvist, A.; Tawa, G. J. Exploring polypharmacology using a ROCS-based target fishing approach J. Chem. Inf. Model. 2012, 52, 492-505
9. Liu, X.; Jiang, H.; Li, H. SHAFTS: A hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening J. Chem. Inf. Model. 2011, 51, 2372-2385
10. Pérez-Nueno, V. I.; Venkatraman, V.; Mavridis, L.; Ritchie, D. W. Detecting drug promiscuity using Gaussian Ensemble Screening J. Chem. Inf. Model. 2012, 52, 1948-1961
11. Meslamani, J.; Li, J.; Sutter, J.; Stevens, A.; Bertrand, H. O.; Rognan, D. Protein-ligand-based pharmacophores: Generation and utility assessment in computational ligand profiling J. Chem. Inf. Model. 2012, 52, 943-955
12. Weill, N.; Rognan, D. Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: Application to G protein-coupled receptors and their ligands J. Chem. Inf. Model. 2009, 49, 1049-1062
13. Paolini, G. V.; Shapland, R. H. B.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global mapping of pharmacological space Nat. Biotechnol. 2006, 24, 805-815
14. Milletti, F.; Vulpetti, A. Predicting polypharmacology by binding site similarity: From kinases to the protein universe J. Chem. Inf. Model. 2010, 50, 1418-1431
15. Weskamp, N.; Hüllermeier, E.; Klebe, G. Merging chemical and biological space: Structural mapping of enzyme binding pocket space Proteins 2009, 76, 317-330
16. Pérez-Nueno, V. I.; Venkatraman, V.; Mavridis, L.; Ritchie, D. W. Predicting drug promiscuity using spherical harmonic (SH) shape-based similarity comparisons Open Conf. Proc. J. 2011, 2, 113-129
17. Meslamani, J.; Bhajun, R.; Martz, F.; Rognan, D. Computational profiling of bioactive compounds using a target-dependent composite workflow J. Chem. Inf. Model. 2013, 53, 2322-2333
18. Simon, Z.; Peragovics, A.; Vigh-Smeller, M.; Csukly, G.; Tombor, L.; Yang, Z.; Zahoránszky-Kohalmi, G.; Végner, L.; Jelinek, B.; Hári, P.; Hetényi, C.; Bitter, I.; Czobor, P.; Málnási-Csizmadia, A. Drug effect prediction by polypharmacology-based interaction profiling J. Chem. Inf. Model. 2012, 52, 134-145
19. Simon, Z.; Vigh-Smeller, M.; Peragovics, A.; Csukly, G.; Zahoránszky-Kohalmi, G.; Rauscher, A. A.; Jelinek, B.; Hári, P.; Bitter, I.; Málnási-Csizmadia, A.; Czobor, P. Relating the shape of protein binding sites to binding affinity profiles: Is there an association? BMC Struct. Biol. 2010, 10, 1-13
20. Campillos, M.; Kuhn, M.; Gavin, A. C.; Jensen, L. J.; Bork, P. Drug target identification using side-effect similarity Science 2008, 321, 263-266
21. Nigsch, F.; Bender, A.; Jenkins, J. L.; Mitchell, J. B. O. Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics J. Chem. Inf. Model. 2008, 48, 2313-2325
22. Niijima, S.; Yabuuchi, H.; Okuno, Y. Cross-target view to feature selection: Identification of molecular interaction features in ligand-target space J. Chem. Inf. Model. 2011, 51, 15-24
23. Takigawa, I.; Tsuda, K.; Mamitsuka, H. Mining significant substructure pairs for interpreting polypharmacology in drug-target network PLoS One 2011, 6 e16999
24. Cheng, F.; Liu, C.; Jiang, J.; Lu, W.; Li, W.; Liu, G.; Zhou, W.; Huang, J.; Tang, Y. Prediction of drug-target interactions and drug repositioning via network-based inference PLoS Comput. Biol. 2012, 8 e1002503
25. Berger, S. I.; Iyengar, R. Network analyses in systems pharmacology Bioinformatics 2009, 25, 2466-2472
26. Pujol, A.; Mosca, R.; Farrés, J.; Aloy, P. Unveiling the role of network and systems biology in drug discovery Trends Pharmacol. Sci. 2010, 31, 115-123
27. CEPOS Mopac; CEPOS InSilico Ltd.: Erlangen, Germany, 2009; http://www.ceposinsilico.de/ (accessed Oct 3, 2013).
28. Ritchie, D. W.; Kemp, G. J. L. Fast computation, rotation, and comparison of low resolution spherical harmonic molecular surfaces J. Comput. Chem. 1999, 20, 383-395
29. Lin, J.; Clark, T. An analytical, variable resolution, complete description of static molecules and their intermolecular binding properties J. Chem. Inf. Model. 2005, 45, 1010-1016
30. Pérez-Nueno, V. I.; Venkatraman, V.; Mavridis, L.; Clark, T.; Ritchie, D. W. Using spherical harmonic surface property representations for ligand-based virtual screening Mol. Inf. 2010, 30, 151-159
31. Pérez-Nueno, V. I.; Ritchie, D. W.; Rabal, O.; Pascual, R.; Borrell, J. I.; Teixidó, J. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking J. Chem. Inf. Model. 2008, 48, 509-533
32. Ritchie, D. W.; Kemp, G. J. L. Protein Docking Using Spherical Polar Fourier Correlations Proteins: Struct., Funct., Genet. 2000, 39, 178-194
33. Pérez-Nueno, V. I.; Ritchie, D. W.; Borrell, J. I.; Teixidó, J. Clustering and classifying diverse HIV entry inhibitors using a novel consensus shape based virtual screening approach: Further evidence for multiple binding sites within the CCR5 extracellular pocket J. Chem. Inf. Model. 2008, 48, 2146-2165
34. Ritchie, D. W.; Pérez-Nueno, V. I. In Scaffold Hopping in Medicinal Chemistry; Brown, N., Ed.; Methods and Principles in Medicinal Chemistry, Vol. 58; Wiley-VCH: Weinheim, Germany, 2013; Chapter 12.
35. Karaboga, A. S.; Petronin, F.; Marchetti, G.; Souchet, M.; Maigret, B. Benchmarking of HPCC: A novel 3D molecular representation combining shape and pharmacophoric descriptors for efficient molecular similarity assessments J. Mol. Graphics Modell. 2013, 41, 20-30
36. Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. DrugBank: A knowledgebase for drugs, drug actions and drug targets Nucleic Acids Res. 2008, 36 (Suppl. 1) D901-D906
37. Ben-Dor, A.; Shamir, R.; Yakhini, Z. Clustering gene expression patterns J. Comput. Biol. 1999, 6, 281-297
38. Lounkine, E.; Keiser, M. J.; Whitebread, S.; Mikhailov, D.; Hamon, J.; Jenkins, J. L.; Lavan, P.; Weber, E.; Doak, A. K.; Côté, S.; Shoichet, B. K.; Urban, L. Large-scale prediction and testing of drug activity on side-effect targets Nature 2012, 486, 361-368
39. Hu, Y.; Bajorath, J. High-resolution view of compound promiscuity F1000Research 2013, 2, 144
40. Mestres, J.; Gregori-Puigjané, E.; Valverde, S.; Solé, R. V. The topology of drug-target interaction networks: Implicit dependence on drug properties and target families Mol. BioSyst. 2009, 5, 1051-1057
41. Little, R.; Rubin, D. B. Statistical Analysis with Missing Data, 2 nd ed.; John Wiley & Sons: New York, 2002.
42. Liu, X.; Zhao, Y. Semi-empirical likelihood inference for the ROC curve with missing data J. Stat. Plann. Inference 2012, 142, 3123-3133
43. Martínez-Camblor, P. Area under the ROC curve comparison in the presence of missing data J. Korean Stat. Soc. 2013, 42, 431-442
44. Xia, J.; Broadhurst, D. I.; Wilson, M.; Wishart, D. S. Metabolomics 2013, 9, 280-299
45. Cobos, E. J.; Entrena, J. M.; Nieto, F. R.; Cendán, C. M.; Del Pozo, E. Curr. Neuropharmacol. 2008, 6, 344-366
46. Ichikawa, J.; Ishii, H.; Bonaccorso, S.; Fowler, W. L.; OLaughlin, I. A.; Meltzer, H. Y. 5-HT2A and D-2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: A possible mechanism of atypical antipsychotic-induced cortical dopamine release J. Neurochem. 2001, 76, 1521-1531
47. DeVore, N. M.; Scott, E. E. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 Nature 2012, 482, 116-119
48. Ostroumov, A.; Simonetti, M.; Nistri, A. Cystic fibrosis transmembrane conductance regulator modulates synaptic chloride homeostasis in motoneurons of the rat spinal cord during neonatal development Dev. Neurobiol. 2011, 71, 253-68
49. Askari, B.; Kanter, J. E.; Sherrid, A. M.; Golej, D. L.; Bender, A. T.; Liu, J.; Hsueh, W. A.; Beavo, J. A.; Coleman, R. A.; Bornfeldt, K. E. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor -independent mechanism in human arterial smooth muscle cells and macrophages Diabetes 2007, 56, 1143-1152
50. Phebus, L. A.; Johnson, K. W.; Zgombick, J. M.; Gilbert, P. J.; Van Belle, K.; Mancuso, V.; Nelson, D. L.; Calligaro, D. O.; Kiefer, A. D., Jr.; Branchek, T. A.; Flaugh, M. E. Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine Life Sci. 1997, 61, 2117-2126